Dana-Farber Receives $25 Million for Cancer Research

Jan 28, 2019 | Cancer Research, Oncology

Researchers at Dana-Farber Cancer Institute have been awarded $25 million for a project that seeks to determine how certain microbes inside the body can lead to colorectal cancer and influence a patient’s response to treatment. The team of doctors beat out more than 130 teams from all over the world to win the Grand Challenge, a competition funded by a cancer treatment and awareness charity in the United Kingdom. Known as the OPTIMISTICC project, the investigators will seek to understand the difference between a healthy microbiome and a microbiome associated with cancer.

Lead Research/Investigators

Matthew Meyerson, MD, PhD

Wendy Garrett, MD, PhD


Pin It on Pinterest